In an era where antibiotic resistance has emerged as one of the most pressing global health threats, a new class of antibiotics is being developed by Kinvard Bio to combat drug-resistant infections.Founded by prominent chemists from Harvard University, this innovative biotechnology startup aims to provide solutions to the growing challenge posed by antibiotic-resistant bacteria.